Ceylinco Healthcare Services Archives

March 13, 2021

Discounts on cost of Radiation Treatment for Cancer
Discounts extended to immediate family members of policyholders

Ceylinco Healthcare Services Limited (CHSL) has announced that life insurance policyholders of Ceylinco Life will be provided discounts of up to 50 per cent for radiation treatment at the Company’s two state-of-the-art cancer treatment centres in Colombo.

Ceylinco Life policyholders whose life insurance policies have been active for more than three years would be eligible for a discount of 50 per cent, while other life policyholders would receive a discount of 25 per cent, the Company said.

These generous discounts, which can represent savings of up to Rs 400,000 or more, will be offered for radiation treatment via the Varian Clinac® iX linear accelerator or via the Accuray TomoHD™ TomoTherapy treatment system. Both treatment centres are located at separate addresses at Park Street, Colombo 2.

Immediate family members of Ceylinco Life’s life policyholders are also entitled to receive these discounts, CHSL said. For the purpose of this offer, immediate family members are identified as the spouse and children of a married policyholder, or the parents of an unmarried policyholder.

“These discounts translate to a very substantial additional benefit to our life policyholders at no added cost, and are an articulation of Ceylinco Life’s commitment to the wellbeing of its policyholders,” CHSL director and Ceylinco Life Managing Director Mr Thushara Ranasinghe said. “They also demonstrate another facet of how Ceylinco Life helps de-risk the future of its policyholders. The Company has invested heavily in cutting-edge cancer treatment equipment and we are happy to be able to pass on the benefit of these investments to our customers, in addition to enhancing the treatment options for the general public.”

The state-of-the-art Clinac® iX linear accelerator purchased by CHSL from Varian Medical Systems, a global leader in Radiation Oncology, and commissioned in December 2018, replaced the original linear accelerator unit which when commissioned in 2007, was the first linear accelerator in the country. The new linear accelerator delivers significant improvements in precision and reduced treatment times, enabling the CHSL’s Radiation Treatment Centre to efficiently deliver wide-ranging radiation therapy treatments including 3D Conformal Radiotherapy, Intensity Modulated Radiotherapy (IMRT) and MV based Image Guided Radiotherapy (IGRT) to treat many forms of cancer.

CHSL’s TomoTherapy Centre is the only one of its kind in Sri Lanka. TomoTherapy is an integrated, advanced form of 3-dimensional image-guided radiation therapy (IGRT). Because a patient’s anatomy can change from day-to-day, image-guided radiation therapy helps doctors make immediate adjustments to allow for tumor movement or shrinkage, weight loss and other changes. TomoTherapy can provide significantly more accurate radiation therapy for even the smallest tumours and reduce treatment times. It can be used to treat cancers all over the body, but is especially effective for prostate cancers, head and neck, pancreatic, left-sided breast, anal and rectal cancers.

A wholly-owned subsidiary of Ceylinco Life, Ceylinco Healthcare Services Limited operates the most experienced and affordable private cancer treatment centres in the country. These centres have successfully administered radiation therapy to over 7,000 patients in Sri Lanka over the past decade.

October 2, 2017

Ceylinco Healthcare Services Ltd. (CHSL) has announced the appointment of Vidya Jyothi Emeritus Prof. Rohan Jayasekara, immediate past Dean of the Faculty of Medicine of the University of Colombo, as its Medical Director.

A pioneer in the specialty of human genetics in Sri Lanka, Prof. Jayasekara, M.B.B.S., Ph.D. (N’Cle.U.K) C.Biol. FRSB (Lond.) Hon. FCSSL, Hon. FCOSL, has had an illustrious administrative, teaching and research career spanning 41 years.

Announcing his appointment, CHSL Chairman Mr R. Renganathan said: “Prof. Jayasekara’s knowledge of medicine and his depth of administrative experience will be invaluable to the development of the three centres of excellence owned by Ceylinco Healthcare Services. His expertise in genetics would also be useful to our efforts to identify and help families predisposed to cancer and diabetes to prevent or delay the onset of these diseases through regular screening and healthy lifestyles.”

An Honorary Fellow of the College of Surgeons of Sri Lanka and an Honorary Fellow of the College of Ophthalmologists of Sri Lanka, Prof. Jayasekara was the Chair and Senior Professor of Anatomy and the Founder Director of the Colombo University’s Human Genetics Unit which he established in 1983.

He is a Fellow of the Galton Institute, London; a Chartered Biologist; a Fellow of the Royal Society of Biology, London; a Commonwealth Scholar and a Commonwealth Senior Medical Fellow. In addition, he holds a PhD in Cytogenetics, which he obtained in 1981 while on a Commonwealth Research Scholarship.

Prof. Jayasekara acquired his postdoctoral experience as a Commonwealth Senior Medical Fellow at Guys Hospital London and the Department of Pathology, University of Cambridge. He was the recipient of numerous World Health Organisation (WHO) Fellowships and Visiting Scientist grants, with which he received further research experience in Genetics at the Centre for Birth Defects in Alabama, the National University of Singapore, Mahidol University in Bangkok, Prince of Wales Hospital in Sydney and at the University of Hong Kong. As a researcher, he has published extensively and is the recipient of the President’s Award for Scientific Publications for the past six years.

His new appointment covers the two Radiation Treatment Centres and the Diabetes Centre operated by Ceylinco Healthcare Services Ltd.

CHSL’s first Radiation Treatment Unit introduced the Linear Accelerator to Sri Lanka in September 2007 and has treated more than 3,600 patients to date. The Linear Accelerator, and the TomoTherapy unit which followed, represent the most advanced treatment techniques available in Sri Lanka in the sphere of radiation oncology. The only one of its kind in Sri Lanka, the Ceylinco TomoTherapy Centre offers a new dimension in high precision image-guided radiation therapy for the treatment of many forms of cancer, and has to date treated 440 patients.

Besides the two radiation treatment units, Ceylinco Healthcare Services owns and operates the Ceylinco Diabetes Centre, offering comprehensive screening, diagnostic services and medical care.

Ceylinco Healthcare offers up to 50% discount for policyholders of Ceylinco Life

Prof. Rohan Jayasekara appointed Medical Director of Ceylinco Healthcare Services